Adjunctive clavulanic acid abolishes the cefazolin inoculum effect in an experimental rat model of methicillin-sensitive Staphylococcus aureus endocarditis
Cargando...
Fecha
2018
Título de la revista
Publicado en
Antimicrobial Agents and Chemotherapy, 1098-6596, Vol. 62, Nro. 11, 2018, p. 1-6
Publicado por
American Society for Microbiology
URL de la fuente
Enlace a contenidos multimedia
ISSN de la revista
Título del volumen
Resumen
Descripción
Abstract
We tested the ability of clavulanic acid to restore the efficacy of cefazolin against Staphylococcus aureus TX0117, which exhibits the cefazolin inoculum effect (CzIE). In the rat infective endocarditis model, the coadministration of cefazolin plus clavulanic acid resulted in a significant reduction of bacterial counts (7.1 ± 0.5 log10 CFU/g) compared to that with cefazolin alone (2 ± 0.6 log10 CFU/g; P < 0.0001). The addition of a β-lactamase inhibitor may be a viable strategy for overcoming the CzIE.
Palabras clave
Keywords
Staphylococcus aureus, Cefazolin, Animal models, Clavulanic acid
Temáticas
Endocarditis
Válvulas Cardíacas
Antibacterianos
Válvulas Cardíacas
Antibacterianos